Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T-cell lymphoma
Robert Stuver, Steven M. Horwitz, Ranjana H. Advani, Julie M. Vose, Hun Ju Lee, Neha Mehta-Shah, Jasmine M. Zain, Bradley Haverkos, Mary Jo Lechowicz, Alison J. Moskowitz, Luu Q. Pham, Elizabeth Leyden, Stephen M. Ansell, Matthew A. Lunning
Dive into the research topics of 'Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T-cell lymphoma'. Together they form a unique fingerprint.